<?xml version='1.0' encoding='utf-8'?>
<document id="20210718"><sentence text="Mechanisms of drug induced QT interval prolongation." /><sentence text="The long QT syndrome (LQTS) is characterized by a prolonged QT interval, as well as a propensity to develop syncope and sudden cardiac death caused by the malignant polymorphic ventricular arrhythmia called torsades de pointes (TdP)" /><sentence text=" The QT interval is measured from the onset of the QRS complex to the end of the T wave and can be affected by both ventricular conduction velocities as well as by the velocity of repolarization" /><sentence text=" In most cases, QT prolongation is caused by factors that prolong the duration of the action potential, mainly by delaying the repolarization phase 3" /><sentence text=" The molecular mechanism is partially known" /><sentence text=" There are two well described mechanisms: blocking of the ion channel cavity of HERG; or causing an abnormal protein trafficking required for the location of HERG subunits in cell membrane" /><sentence text=" Both of them impair the I(Kr) current" /><sentence text=" However the blockade of ion channels is not the only condition to generate TdP" /><sentence text=" Other factors may play an important role, e" /><sentence text="g" /><sentence text=" myocardium heterogeneity, drug-drug interaction, genetic polymorphism, and Electrolyte disturbances" /><sentence text=" Several drugs had been subject of withdrawal because QT-prolongation and arrhythmia" /><sentence text=" Understanding of processes involved in drug-induced QT prolongation is needed for the study and prevention of life-threatening arrhythmias" /><sentence text="" /></document>